Voyager Therapeutics (NASDAQ:VYGR) Coverage Initiated by Analysts at Cantor Fitzgerald
Cantor Fitzgerald assumed coverage on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a research note published on Friday morning, Marketbeat reports. The firm issued an overweight rating and a $5.
In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on PTC Therapeutics (PTCT – Research Report), ...
IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report)‘s stock had its “overweight” rating restated by Cantor Fitzgerald in a ...
Cantor Fitzgerald is charged with violating antifraud and proxy provisions. Former Comtech CEO is charged with insider trading ahead of negative earnings. The Securities and Exchange Commission on ...
In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Amicus (FOLD – Research Report), with a price ...
The Securities and Exchange Commission charged Cantor Fitzgerald with violating laws related to disclosures by so-called blank-check companies before they raise money from the public. Cantor ...
Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...
Cantor Fitzgerald Equity Opportunity Fd earns a Low Process Pillar rating. The primary detractor from the rating is the fund's unimpressive long-term risk-adjusted performance. This can be seen in ...
Cantor Fitzgerald & Co. has made some new hires to its financial institutions group, including Vishal Sitapara from Jefferies Financial Group Inc. Sitapara was a managing director at Jefferies ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks ...
Applied Digital Corp (NASDAQ:APLD) shares are trading lower Wednesday on the heels of the company's second-quarter financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback